2) disease-free survival
无病生存
1.
Objiect:To study the prognostic factor and evaluate the effect of perioperative allogeneic blood transfusions on disease-free survival in non-small cell lung cancer patients treated with curative pulmonary resection; to clarify the influence of allogeneic blood transfusion on cell adhesion characteristic of plasma.
目的 探讨非小细胞肺癌患者术后的预后相关因素，研究围手术期输血对其术后无病生存的影响；研究输血对血浆细胞粘附特性的影响。
3) disease free survival
无病生存期
1.
Objective To investigate the adverse effect,disease free survival and overall survival of dose-dense chemotherapy in postoperative breast cancer patients.
目的观察剂量密度化疗治疗乳腺癌的不良反应及对无病生存期和总生存期的影响。
4) disease-free survival
无病生存期
1.
Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection
术后辅助化疗时间对Ⅲ期和高危Ⅱ期结直肠癌3年无病生存期的影响
2.
Objective: To evaluate whether adjuvant chemotherapy prolongs disease-free survival among patients with completely resected early-stage non–small-cell lung cancer (NSCLC) in elderly patients and the toxicity and safety of the regimen.
结果:两组接受术后辅助化疗后具有相似的无病生存期(P>0。
3.
Influence of perioperative blood transfusion on disease-free survival in non-small cell lung cancer patients;
无病生存期分析采用多因素Cox回归模型 ,并绘制生存曲线 。
5) recurrence free survival rate
无瘤生存率
1.
Purpose To study factors influencing recurrence free survival rate of salivary adenoid cystic carcinoma(SACC).
方法分析118例有完整随访资料的唾液腺腺样囊性癌患者病例资料,Kaplan-Meier 法计算各时点的无瘤生存率,并绘制生存曲线。
补充资料：生存率
生存率
生存率即病人能活到某时间的生存几率。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条